Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMICGeneric

OCUSERT PILO-20

PILOCARPINE

Standard Dose
5MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Discontinued
Summary

Approval overview OCUSERT PILO-20 is listed in Drugs@FDA under application 017431 (NDA).

Review priority: PRIORITY Marketing status: Discontinued Active ingredient PILOCARPINE Form and strength INSERT, EXTENDED RELEASE;OPHTHALMIC - 5MG Sponsor EPIC PHARMA LLC Submission history Latest submission status date: 1999-01-20 00:00:00.

Structured Monograph

Clinical summary

Approval overview OCUSERT PILO-20 is listed in Drugs@FDA under application 017431 (NDA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient PILOCARPINE Form and strength INSERT, EXTENDED RELEASE;OPHTHALMIC - 5MG Sponsor EPIC PHARMA LLC Submission history Latest submission status date: 1999-01-20 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: PRIORITY

Interaction Notes

  • No interaction notes stored yet.